Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Other financing activities (2010 - 2026)

Exelixis (EXEL) posted quarterly Other financing activities of $7.5 million for Q2 2026, down 35.74% year-over-year from $11.6 million in Q2 2025, and down 5.12% quarter-over-quarter from $7.9 million in Q1 2026.

Analysis

Exelixis (EXEL) Other financing activities (2010 - 2026) Analysis & Trends

Exelixis' Other financing activities history runs 17 years deep, the most recent figure standing at $7.5 million for Q2 2026.

  • In Q2 2026, Other financing activities fell 35.74% year-over-year to $7.5 million; the TTM figure through Apr 2026 stood at $45.0 million (down 30.97% YoY), while the FY2026 annual figure was $49.1 million, down 20.55% from the prior year.
  • Other financing activities for Q2 2026 stood at $7.5 million, down from $7.9 million in the prior quarter.
  • The five-year high for Other financing activities was $26.1 million in Q3 2025, with the low at $2.9 million in Q3 2022.
  • The 5-year median for Other financing activities is $8.3 million (2024), against an average of $10.3 million.
  • The sharpest annual moves came in 2024 and 2025: Other financing activities jumped 186.09% in 2024, then slumped 82.05% in 2025.
  • Exelixis' Other financing activities stood at $5.2 million in 2022, then surged by 74.97% to $9.1 million in 2023, then surged by 117.25% to $19.8 million in 2024, then plunged by 82.05% to $3.6 million in 2025, then surged by 110.36% to $7.5 million in 2026.
  • Business Quant data shows EXEL's Other financing activities at $7.5 million in Q2 2026, $7.9 million in Q1 2026, and $3.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 15.44 Mn
Apr 3, 2026 7.47 Mn
Jan 2, 2026 7.88 Mn
Oct 3, 2025 3.55 Mn
Jul 4, 2025 26.08 Mn
Apr 4, 2025 11.63 Mn
Jan 3, 2025 18.82 Mn
Sep 27, 2024 19.79 Mn
Jun 28, 2024 14.92 Mn
Mar 29, 2024 8.32 Mn
Dec 29, 2023 9.11 Mn
Sep 29, 2023 6.92 Mn
Jun 30, 2023 10.28 Mn
Mar 31, 2023 7.14 Mn
Dec 30, 2022 5.21 Mn
Sep 30, 2022 2.89 Mn
Jul 1, 2022 10.90 Mn
Apr 1, 2022 4.89 Mn
Dec 31, 2021 6.07 Mn
Oct 1, 2021 2.76 Mn